NCT05683795

Brief Summary

The empty pelvis syndrome is an unsolved and poorly defined problem severely affecting patients that have pelvic exenteration surgery, and also the teams looking after them. It is unclear what the anatomical and pathophysiological causes of the empty pelvis syndrome are, how it can be prevented, and how its sequelae can be measured. The evidence to guide decisions around the empty pelvis syndrome is of low quality, and so there is a large amount of variation in approaches between different hospitals. This consensus study will define a core outcome set for the empty pelvis syndrome, and establish current levels of consensus on pathophysiology and mitigation of the empty pelvis syndrome through a modified-Delphi process involving both healthcare professionals and patient representatives.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 3, 2023

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

January 4, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

January 13, 2023

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2023

Completed
Last Updated

January 13, 2023

Status Verified

January 1, 2023

Enrollment Period

8 months

First QC Date

January 4, 2023

Last Update Submit

January 4, 2023

Conditions

Keywords

Empty Pelvis SyndromePelvic Exenteration

Outcome Measures

Primary Outcomes (1)

  • A core outcome set for the empty pelvis syndrome

    Consensus process involving both healthcare professionals and patient representatives to define measurable outcomes for the empty pelvis syndrome

    8 months

Secondary Outcomes (2)

  • Consensus on pathophysiology of the empty pelvis syndrome

    8 months

  • Consensus on mitigation of the empty pelvis syndrome using reconstructive techniques

    8 months

Study Arms (2)

Healthcare Professionals

Members of The PelvEx Collaborative who are experts in performing pelvic exenteration surgery, and managing the complications relating to the empty pelvis syndrome as a result of this surgery.

Other: Consensus study

Patient Representatives

Patients that have undergone pelvic exenteration surgery and likely to have been exposed to the morbidity of the empty pelvis syndrome.

Other: Consensus study

Interventions

Modified-Delphi study and consensus meetings

Healthcare ProfessionalsPatient Representatives

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

An international cohort of patients that have undergone pelvic exenteration surgery, and an international group of expert clinicians who perform pelvic exenteration surgery (The PelvEx Collaborative).

You may qualify if:

  • Healthcare professional and member of The PelvEx Collaborative
  • Patient representative that has undergone pelvic exenteration surgery - defined as surgery to remove multiple organs from the pelvis, including beyond total mesorectal excision plane operations, for any pelvic malignancy (i.e., primary or recurrent colorectal, gynaecological, urological, and connective tissue disease)
  • Non-English speaking healthcare professionals and patient representatives where language translation is possible.

You may not qualify if:

  • Patient representatives that have not undergone pelvic exenteration surgery.
  • Non-English speaking healthcare professionals and patient representatives where language translation is not possible.
  • Individuals unable to take part in the online consensus process, or unable to give online consent digitally.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Southampton

Southampton, Hampshire, SO16 6YD, United Kingdom

Location

Related Publications (5)

  • Johnson YL, West MA, Gould LE, Drami I, Behrenbruch C, Burns EM, Mirnezami AH, Jenkins JT. Empty pelvis syndrome: a systematic review of reconstruction techniques and their associated complications. Colorectal Dis. 2022 Jan;24(1):16-26. doi: 10.1111/codi.15956. Epub 2021 Oct 25.

    PMID: 34653292BACKGROUND
  • Sutton PA, Brown KGM, Ebrahimi N, Solomon MJ, Austin KKS, Lee PJ. Long-term surgical complications following pelvic exenteration: Operative management of the empty pelvis syndrome. Colorectal Dis. 2022 Dec;24(12):1491-1497. doi: 10.1111/codi.16238. Epub 2022 Jul 19.

    PMID: 35766998BACKGROUND
  • Blazeby JM, Macefield R, Blencowe NS, Jacobs M, McNair AG, Sprangers M, Brookes ST; Research Group of the Core Outcomes and iNformation SEts iN SUrgical Studies-Oesophageal Cancer; Consensus Group of the Core Outcomes and iNformation SEts iN SUrgical Studies-Oesophageal Cancer. Core information set for oesophageal cancer surgery. Br J Surg. 2015 Jul;102(8):936-43. doi: 10.1002/bjs.9840. Epub 2015 May 18.

    PMID: 25980524BACKGROUND
  • Innes K, Hudson J, Banister K, Croal B, Ramsay C, Ahmed I, Blazeby J, Gillies K; CGALL Trial Group. Core outcome set for symptomatic uncomplicated gallstone disease. Br J Surg. 2022 Apr 5:znac095. doi: 10.1093/bjs/znac095. Online ahead of print.

    PMID: 35381067BACKGROUND
  • PelvEx Collaborative. Beating the empty pelvis syndrome: the PelvEx Collaborative core outcome set study protocol. BMJ Open. 2024 Feb 5;14(2):e076538. doi: 10.1136/bmjopen-2023-076538.

MeSH Terms

Conditions

Pelvic NeoplasmsRectal NeoplasmsPostoperative Complications

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsColorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsDigestive System DiseasesGastrointestinal DiseasesIntestinal DiseasesRectal DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Charles T West, MBBS BSc

    University of Southampton

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 4, 2023

First Posted

January 13, 2023

Study Start

January 3, 2023

Primary Completion

August 31, 2023

Study Completion

August 31, 2023

Last Updated

January 13, 2023

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared outside of University of Southampton, between Delphi rounds identifiable information will be anonymised and non-attributable to participants. Anonymised or statistical data may be used publicly or shared with third parties.

Locations